Sign in
GPS mobility as a digital biomarker of negative symptoms in schizophrenia: a case control study
Journal article   Open access

GPS mobility as a digital biomarker of negative symptoms in schizophrenia: a case control study

Colin A Depp, Jesse Bashem, Raeanne C Moore, Jason L Holden, Tanya Mikhael, Joel Swendsen, Philip D Harvey and Eric L Granholm
NPJ Digital Medicine, Vol.2(1), pp.108-108
2019-11-08
PMCID: PMC6841669
PMID: 31728415

Abstract

Health care Medical research
url
https://doi.org/10.1038/s41746-019-0182-1View
Published (Version of record) Open

Metrics

InCites Highlights

These are selected metrics from InCites Benchmarking & Analytics tool, related to this output

Collaboration types
Domestic collaboration
International collaboration
Citation topics
1 Clinical & Life Sciences
1.21 Psychiatry
1.21.24 Schizophrenia
Web Of Science research areas
Health Care Sciences & Services
Medical Informatics
ESI research areas
Clinical Medicine

UN Sustainable Development Goals (SDGs)

This output has contributed to the advancement of the following goals:

#3 Good Health and Well-Being

Source: InCites

Details